Scarlath Ohana P. dos Santos

Scarlath Ohana P. dos Santos

Auto-generated profile, based on publicly available information

Scarlath Ohana P. dos Santos

Department of Clinical Surgery, Veterinary Hospital, Animal Experimental Unit, UENF, 2000 Alberto Lamego, Campos dos Goytacazes, Rio de Janeiro, Brazil

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
PCPaula Gebe Abreu Cabral
Paula Gebe Abreu Cabral
SSSávio Bastos de Souza
Sávio Bastos de Souza
BMBrunna Xavier Martins
Brunna Xavier Martins
SSScarlath Ohana P. dos Santos
Scarlath Ohana P. dos Santos
SCSilvia M. R. Cadena
Silvia M. R. Cadena
AFArnoldo Rocha Façanha
Arnoldo Rocha Façanha
A bstract: Phenotypic, genetic and metabolic tumour heterogeneity is a major factor contributing to cancer progression, metastasis, and resistance to therapy. Distinctive thermal and proton flux patterns can occur in cancer cells as a function of variations in the metabolic rate of the tumour mass, tumour margins, and normal tissues, which can be detected by video thermometry (VTM) as well as by Scanning Ion-selective Electrode Techniques (SIET). This study presents distinct thermal patterns associated with tumour heterogeneity observed in canine mammary cancer using VTM and investigate the correlation between these thermometric signatures with metabolic changes related to V-ATPase activity by comparing real-time VTM data with that from concanamycin-sensitive ATP hydrolysis and cell proton flux measurements. The results demonstrate that integrating SIET and VTM data sets can reveal metabolic signatures to assist the diagnosis, surgery and therapeutic monitoring. Considering the breast cancer hallmarks conservation in human, canines and other mammals, this study provides a first bioenergetic proof-of-concept for the potential of the integration of the VTM technology with enzymatic and electrophysiological analyses sensitive to concanamycin for the development of more effective diagnostic, prognostic and therapeutic approaches in veterinary as well as in preclinical medical studies.